| Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
|---|
| Anagrelide | hsa00190 | Oxidative phosphorylation | 1.07E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | | Anagrelide | hsa03040 | Spliceosome | 2.09E-02 | 7 | Q14562, O43143, O75940, O75494, Q07955, Q01130, Q13243 | DHX8, DHX15, SMNDC1, FUSIP1, SFRS1, SFRS2, SFRS5 | More | | | Anagrelide | hsa04014 | Ras signaling pathway | 1.70E-02 | 7 | P20827, Q9NRA1, P49767, P17252, P0DP23, P62873, P19174 | EFNA1, PDGFC, VEGFC, PRKCA, CALM1, GNB1, PLCG1 | More | | | Anagrelide | hsa04015 | Rap1 signaling pathway | 4.58E-02 | 6 | P20827, Q9NRA1, P49767, P0DP23, P17252, P19174 | EFNA1, PDGFC, VEGFC, CALM1, PRKCA, PLCG1 | More | | | Anagrelide | hsa04020 | Calcium signaling pathway | 2.01E-02 | 6 | P17252, P19174, P0DP23, P20020, Q9NRA1, P49767 | PRKCA, PLCG1, CALM1, ATP2B1, PDGFC, VEGFC | More | | | Anagrelide | hsa04070 | Phosphatidylinositol signaling system | 4.40E-02 | 4 | P19174, P0DP23, P23743, P17252 | PLCG1, CALM1, DGKA, PRKCA | More | | | Anagrelide | hsa04145 | Phagosome | 4.68E-02 | 5 | Q15080, P14598, Q13509, P68371, Q13488 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1 | More | | | Anagrelide | hsa04217 | Necroptosis | 1.36E-02 | 7 | P01568, P42224, P08238, Q6FI13, Q93077, O43633, Q08752 | IFNA21, STAT1, HSP90AB1, H2AC18; H2AC19, HIST1H2AC, CHMP2A, PPID | More | | | Anagrelide | hsa04360 | Axon guidance | 2.29E-02 | 5 | P16333, P20827, O95631, P17252, P19174 | NCK1, EFNA1, NTN1, PRKCA, PLCG1 | More | | | Anagrelide | hsa04540 | Gap junction | 1.67E-02 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | | Anagrelide | hsa04623 | Cytosolic DNA-sensing pathway | 3.29E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | | Anagrelide | hsa04657 | IL-17 signaling pathway | 2.97E-02 | 5 | P25963, P08238, Q07955, P04141, P06702 | NFKBIA, HSP90AB1, SFRS1, CSF2, S100A9 | More | | | Anagrelide | hsa04660 | T cell receptor signaling pathway | 3.80E-02 | 6 | P04141, P25963, P10747, P19174, P16333, P29350 | CSF2, NFKBIA, CD28, PLCG1, NCK1, PTPN6 | More | | | Anagrelide | hsa04713 | Circadian entrainment | 3.32E-02 | 4 | P0DP23, P17252, P62873, O15055 | CALM1, PRKCA, GNB1, PER2 | More | | | Anagrelide | hsa04744 | Phototransduction | 1.18E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | | Anagrelide | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.72E-02 | 5 | P42224, Q12778, P49767, P17252, P19174 | STAT1, FOXO1, VEGFC, PRKCA, PLCG1 | More | | | Anagrelide | hsa05012 | Parkinson disease | 3.12E-02 | 6 | Q16718, O14521, P19174, P0DP23, Q13509, P68371 | NDUFA5, SDHD, PLCG1, CALM1, TUBB3, TUBB2C | More | | | Anagrelide | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.29E-02 | 9 | Q13509, P68371, Q16718, O14521, Q13561, P19174, P17252, Q08752, P0DP23 | TUBB3, TUBB2C, NDUFA5, SDHD, DCTN2, PLCG1, PRKCA, PPID, CALM1 | More | | | Anagrelide | hsa05110 | Vibrio cholerae infection | 1.98E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | | Anagrelide | hsa05132 | Salmonella infection | 1.70E-02 | 8 | P25963, P08238, P04406, O75369, Q13561, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, GAPDH, FLNB, DCTN2, TUBB3, TUBB2C, VPS41 | More | | | Anagrelide | hsa05140 | Leishmaniasis | 1.72E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | | | Anagrelide | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 5.71E-03 | 8 | P01568, P42224, P25963, P40189, P62873, P19174, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, IL6ST, GNB1, PLCG1, CSF2, CALM1 | More | | | Anagrelide | hsa05168 | Herpes simplex virus 1 infection | 4.15E-03 | 12 | P25963, P01568, Q9GZY0, P42224, Q07955, Q01130, Q13243, Q13398, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, NXF2; NXF2B, STAT1, SFRS1, SFRS2, SFRS5, ZNF211, ZNF85, ZNF140, ZNF189, ZNF212 | More | | | Anagrelide | hsa05171 | Coronavirus disease - COVID-19 | 1.36E-02 | 7 | P25963, P42224, P01568, P40189, P04141, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, CSF2, PLCG1, PRKCA | More | | | Anagrelide | hsa05200 | Pathways in cancer | 1.75E-02 | 14 | P08238, P42224, P25963, P19174, P17252, P43246, P14923, P49767, Q12778, P62873, O75293, P0DP23, P01568, P40189 | HSP90AB1, STAT1, NFKBIA, PLCG1, PRKCA, MSH2, JUP, VEGFC, FOXO1, GNB1, GADD45B, CALM1, IFNA21, IL6ST | More | | | Anagrelide | hsa05214 | Glioma | 1.09E-02 | 4 | P0DP23, P17252, P19174, O75293 | CALM1, PRKCA, PLCG1, GADD45B | More | | | Anagrelide | hsa05231 | Choline metabolism in cancer | 2.25E-03 | 5 | Q9NRA1, Q9Y259, P19174, P23743, P17252 | PDGFC, CHKB, PLCG1, DGKA, PRKCA | More | | | Anagrelide | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.97E-02 | 5 | P25963, P19174, P29350, P42224, P10747 | NFKBIA, PLCG1, PTPN6, STAT1, CD28 | More | | | Anagrelide | hsa05415 | Diabetic cardiomyopathy | 1.20E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | |
|
